The accompanying notes are an integral part
of these financial statements.
The accompanying notes are an integral part
of these financial statements.
The accompanying notes are an integral part
of these financial statements.
Notes to Financial Statements
June 30, 2016 and December 31, 2015
(Unaudited)
Note A - Organization and Description of Business
HPC Acquisitions, Inc. (the “Company”) was initially
formed under the laws of the State of Minnesota as Herky Packing Co. on July 17, 1968. The Company initially produced and marketed
meat snack foods, principally beef jerky, smoked dried beef and snack sausages, through food brokers, distributors and wagon jobbers.
Despite a 1970 restructuring, including the relocation to an approximate 12,500 square foot production facility, the Company’s
efforts were unsuccessful and all operations were terminated by the end of 1970. On April 10, 1972, the Company changed its corporate
name to H. P. C. Incorporated. In connection with this name change, the Company acquired Ed Stein’s Tire Center, Inc, a Minneapolis,
Minnesota-based distributor of Gates tires. This acquisition was unsuccessful and reversed in 1973.
On August 7, 2006, the Company changed its state of incorporation
from Minnesota to Nevada by means of a merger with and into HPC Acquisitions, Inc., a Nevada corporation formed on June 12, 2006
solely for the purpose of effecting the reincorporation. The Articles of Incorporation and Bylaws of the Nevada corporation are
the Articles of Incorporation and Bylaws of the surviving corporation. Such Articles of Incorporation modified the Company’s
capital structure to allow for the issuance of up to 50,000,000 shares of $0.001 par value common stock and up to 10,000,000 shares
of $0.001 par value preferred stock.
On March 8, 2016, the Company sold 12,011,000 shares of its
common stock to David Selakovic at a total cash purchase price of $303,100. This transaction effected a change in management and
control of the Company. Mr. Selakovic assigned to the Company certain assets consisting of the exclusive right to distribute in
the Western Hemisphere natural agrochemicals developed by ECOWIN Co., Ltd., a Korean company, certain state permits for the sale
of ECOWIN agrochemicals, and the trademark “Vegalab” (the “DS Assets”). Our new plan of operation is to
commence the business of selling ECOWIN products under the brand name “Vegalab”.
The Company is currently in the business of selling the ECOWIN
products under the “Vegalab” name in the United States of America. The Company’s current sole source of supply
of ECOWIN products is through Vegalab S. A., a Swiss company solely owned by David Selakovic, the Company’s controlling shareholder
and sole officer and director.
Note B - Preparation of Financial Statements
The Company follows the accrual basis of accounting in accordance
with generally accepted accounting principles and has a fiscal year-end of December 31.
The preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those
estimates.
Management further acknowledges that it is solely responsible
for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and
detecting fraud. The Company’s system of internal accounting control is designed to assure, among other items, that 1) recorded
transactions are valid; 2) valid transactions are recorded; and 3) transactions are recorded in the proper period in a timely manner
to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company
for the respective periods being presented.
For segment reporting purposes, the Company operated in only
one industry segment during the periods represented in the accompanying financial statements and makes all operating decisions
and allocates resources based on the best benefit to the Company as a whole.
During interim periods, the Company follows the accounting policies
set forth in its annual audited financial statements filed with the U. S. Securities and Exchange Commission on its Annual Report
on Form 10-K for the year ended December 31, 2015. The information presented within these interim financial statements may not
include all disclosures required by accounting principles generally accepted in the United States of America and the users of financial
information provided for interim periods should refer to the annual financial information and footnotes when reviewing the interim
financial results presented herein.
In the opinion of management, the accompanying interim financial
statements, prepared in accordance with the U. S. Securities and Exchange Commission’s instructions for Form 10-Q, are unaudited
and contain all material adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial
condition, results of operations and cash flows of the Company for the respective interim periods presented. The current period
results of operations are not necessarily indicative of results which ultimately will be reported for the full fiscal year ending
December 31, 2016.
Note C - Going Concern Uncertainty
The Company’s business plan is to distribute, in the Western
Hemisphere, certain natural agrochemicals developed by ECOWIN Co., Ltd., a Korean company, under the brand name “Vegalab”.
However, there is no assurance that the Company will be able to successfully penetrate its targeted market or that the implementation
of said business plan will result in the appreciation of our stockholders’ investment in the then outstanding common stock.
The Company's continued existence is dependent upon its ability
to generate sufficient cash flows from operations to support its daily operations as well as provide sufficient resources to retire
existing liabilities and obligations on a timely basis. The Company faces considerable risk in its business plan. If insufficient
operating capital is available during the next twelve months, the Company will be forced to rely on existing cash in the bank and
additional funds loaned by management and/or significant stockholders.
The Company’s former majority stockholder previously provided
the necessary working capital to maintain the corporate status of the Company. It is the current intent of management and significant
stockholders to provide sufficient working capital, if necessary, to support and preserve the integrity of the corporate entity.
However, no formal commitments or arrangements to advance or loan funds to the Company or repay any such advances or loans exist.
There is no legal obligation for either management or significant stockholders to provide additional future funding.
The Company anticipates offering future sales of equity securities.
However, there is no assurance that the Company will be able to obtain additional funding through the sales of additional equity
securities or, that such funding, if available, will be obtained on terms favorable to or affordable by the Company.
The Company’s certificate of incorporation authorizes
the issuance of up to 10,000,000 shares of preferred stock and 50,000,000 shares of common stock. The Company’s ability to
issue preferred stock may limit the Company’s ability to obtain debt or equity financing as well as impede potential takeover
of the Company, which takeover may be in the best interest of stockholders. The Company’s ability to issue these authorized
but unissued securities may also negatively impact our ability to raise additional capital through the sale of our debt or equity
securities.
In such a restricted cash flow scenario, the Company would be
unable to complete its business plan steps, and would, instead, delay all cash intensive activities. Without necessary cash flow,
the Company may become dormant during the next twelve months, or until such time as necessary funds could be raised in the equity
securities market.
While the Company is of the opinion that good faith estimates
of the Company’s ability to secure additional capital in the future to reach its goals have been made, there is no guarantee
that the Company will receive sufficient funding to sustain operations or implement any future business plan steps.
Note D - Summary of Significant Accounting Policies
|
1.
|
Cash and cash equivalents
|
The Company considers all cash on hand and in banks,
certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash
and cash equivalents.
|
2.
|
Concentrations of credit risk
|
Sales
to one customer comprised 98% of the Company’s total revenues and 97% of accounts receivable for the six months ended June
30, 2016. The Company believes that, in the event that its primary customers are unable or unwilling to continue to purchase the
Company’s good, there are a number of alternative customers at comparable prices.
In the normal course of business, the Company extends
unsecured credit to virtually all of its customers which are located throughout the United States. Because of the credit risk involved,
management has provided an allowance for doubtful accounts which reflects its opinion of amounts which will eventually become uncollectible.
In the event of complete non-performance, the maximum exposure to the Company is the recorded amount of trade accounts receivable
shown on the balance sheet at the date of non-performance.
Inventory consists of finished goods related to the
sale of certain natural agrochemicals developed by ECOWIN Co., Ltd., a Korean company, under the brand name “Vegalab”.
Inventory is valued at the lower of cost or market using the first-in, first-out method. A change in income is taken when factors
that would result in a need for a reduction in the valuation, such as excess or obsolete inventory, are noted.
Revenue
is recognized when the earnings process is completed, the risks and rewards of ownership have transferred to the customer, which
is generally the same day as delivery or shipment of the product, the price to the buyer is fixed or determinable, and collection
is reasonably assured. All sales are recorded when the goods are shipped.
The Company ships all product on an FOB-Plant, “as-is”
basis. Accordingly, revenue is recognized by the Company at the point at which an order is shipped at a fixed price, collection
is reasonably assured and the Company has no remaining performance obligations related to the sale. The Company sells all products
with “no right of return” by the purchaser for any factor other than defects in the product’s production.
The Company files income tax returns in the United
States of America and may file, as applicable and appropriate, various state(s). With few exceptions, the Company is no longer
subject to U.S. federal, state and local, as applicable, income tax examinations by regulatory taxing authorities for years ending
before December 31, 2013. The Company does not anticipate any examinations of returns filed since January 1, 2014.
The Company uses the asset and liability method of
accounting for income taxes. At June 30, 2016 and December 31, 2015, respectively, the deferred tax asset and deferred tax liability
accounts, as recorded when material to the financial statements, are entirely the result of temporary differences. Temporary differences
generally represent differences in the recognition of assets and liabilities for tax and financial reporting purposes, primarily
accumulated depreciation and amortization, allowance for doubtful accounts and vacation accruals.
The Company has adopted the provisions required by
the Income Taxes topic of the FASB Accounting Standards Codification. The Codification Topic requires the recognition of potential
liabilities as a result of management’s acceptance of potentially uncertain positions for income tax treatment on a “more-likely-than-not”
probability of an assessment upon examination by a respective taxing authority. As a result of the implementation of Codification’s
Income Tax Topic, the Company did not incur any liability for unrecognized tax benefits.
|
6.
|
Income (Loss) per share
|
Basic earnings (loss) per share is computed by dividing
the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding during the respective
period presented in our accompanying financial statements.
Fully diluted earnings (loss) per share is computed
similar to basic income (loss) per share except that the denominator is increased to include the number of common stock equivalents
(primarily outstanding options and warrants).
Common stock equivalents represent the dilutive effect
of the assumed exercise of the outstanding stock options and warrants, using the treasury stock method, at either the beginning
of the respective period presented or the date of issuance, whichever is later, and only if the common stock equivalents are considered
dilutive based upon the Company’s net income (loss) position at the calculation date.
As of June 30, 2016 and 2015, the Company had no
outstanding stock warrants, options or convertible securities which could be considered as dilutive for purposes of the loss per
share calculation.
|
7.
|
Recent Accounting Pronouncements
|
In May 2014, the Financial Accounting Standards
Board issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which
supersedes nearly all existing revenue recognition guidance under GAAP. The core principle of ASU 2014-09 is to recognize revenues
when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects
to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing
so, more judgment and estimates may be required within the revenue recognition process than are required under existing GAAP. The
standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following
transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period
with the option to elect certain practical expedients; or (ii) a retrospective approach with the cumulative effect of initially
adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). The Company is currently
evaluating the impact of its pending adoption of ASU 2014-09 on its consolidated financial statements and have not yet determined
the method by which the Company will adopt the standard in 2017.
The Company does not expect the adoption of recently
issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position
or cash flows.
Note E - Fair Value of Financial Instruments
The carrying amount of cash, accounts receivable, accounts payable
and notes payable, as applicable, approximates fair value due to the short term nature of these items and/or the current interest
rates payable in relation to current market conditions.
Interest rate risk is the risk that the Company’s earnings
are subject to fluctuations in interest rates on either investments or on debt and is fully dependent upon the volatility of these
rates. The Company does not use derivative instruments to moderate its exposure to interest rate risk, if any.
Financial risk is the risk that the Company’s earnings
are subject to fluctuations in interest rates or foreign exchange rates and are fully dependent upon the volatility of these rates.
The Company does not use derivative instruments to moderate its exposure to financial risk, if any.
Note F - Related Party Transactions
The Company’s current sole source of supply of
ECOWIN products is through Vegalab S. A., a Swiss company solely owned by David Selakovic, the Company’s controlling
shareholder. During the quarter ended June 30, 2016, the Company incurred approximately $1,712,978 for
product purchases for resale from Vegalab S. A.
As of June 30, 2016, the Company had outstanding accounts payable
– related party of $736,228 and $0, respectively.
Note G - Notes Payable to Investors
During 2014, the Company borrowed an aggregate $122,300 on
eight (8) separate promissory notes payable to six (6) separate unrelated third parties. These notes bear interest at either 5.0%
or 6.0% per annum and were due on the earlier of October 1, 2015 or upon closing by the Company of a financing in the amount of
$1,000,000 or more. These notes were paid in full by March 31, 2016.
|
|
June 30,
|
|
|
December 31,
|
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
Outstanding principal
|
|
$
|
-
|
|
|
$
|
122,300
|
|
Accrued interest payable
|
|
|
-
|
|
|
|
2,215
|
|
|
|
|
|
|
|
|
|
|
Total obligation outstanding
|
|
$
|
-
|
|
|
$
|
124,515
|
|
Note H - Note Payable to Controlling Stockholder
The Company and its former controlling stockholder, Craig Laughlin,
agreed, in previous periods, that additional funds would be necessary to support the corporate entity and comply with the periodic
reporting requirements of the Securities Exchange Act of 1934, as amended. To this end, Mr. Laughlin agreed to lend the Company
up to $50,000 with a original maturity period not to exceed three (3) years from the initial funding date at an interest rate of
6.0% per annum. The maturity date was subsequently extended to September 2010 and, post-maturity, became due upon demand. During
the quarter ended March 31, 2016, the Company paid this note and all accrued interest in full.
Note I - Income Taxes
The components of income tax (benefit) expense for each of the
six month periods ended June 30, 2016 and 2015, respectively, are as follows:
|
|
Six Months
|
|
|
Six Months
|
|
|
|
Ended
|
|
|
Ended
|
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2016
|
|
|
2015
|
|
Federal:
|
|
|
|
|
|
|
|
|
Current
|
|
$
|
64,800
|
|
|
$
|
-
|
|
Deferred
|
|
|
-
|
|
|
|
-
|
|
|
|
|
64,800
|
|
|
|
-
|
|
State:
|
|
|
|
|
|
|
|
|
Current
|
|
|
-
|
|
|
|
-
|
|
Deferred
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
64,800
|
|
|
$
|
-
|
|
As of June 30, 2016, the Company has an aggregate
net operating loss carryforward of approximately $320,000, of which a portion are subject to limitations for federal and state
tax purposes. The ultimate utilization of this net operating loss carryforward will be subject to the limitations set forth in the
Internal Revenue Code. Such factors as the number of shares ultimately issued within a three year look-back period; whether
there is a deemed more than 50 percent change in control; the applicable long-term tax exempt bond rate; continuity of
historical business; and subsequent income of the Company all enter into the annual computation of allowable annual
utilization of any net operating loss carryforward(s).
The Company's income tax expense for each of the six
months ended June 30, 2016 and 2015, respectively, differed from the statutory federal rate of 34 percent as follows:
|
|
Six Months
|
|
|
Six Months
|
|
|
|
Ended
|
|
|
Ended
|
|
|
|
June 30, 2016
|
|
|
June 30, 2015
|
|
Statutory rate applied to income before income taxes
|
|
$
|
71,100
|
|
|
$
|
(10,500
|
)
|
Increase (decrease) in income taxes resulting from:
|
|
|
|
|
|
|
|
|
State income taxes
|
|
|
-
|
|
|
|
-
|
|
Other, including reserve for deferred tax assets and application of net operating loss carryforward
|
|
|
(6,300
|
)
|
|
|
10,500
|
|
|
|
|
|
|
|
|
|
|
Income Tax Expense
|
|
$
|
64,800
|
|
|
$
|
-
|
|
Temporary differences, consisting primarily of the prospective
usage of net operating loss carryforwards give rise to deferred tax assets and liabilities as of June 30, 2016 and December 31,
2015, respectively:
|
|
June 30,
|
|
|
December 31,
|
|
|
|
2016
|
|
|
2015
|
|
Deferred tax assets
|
|
|
|
|
|
|
|
|
Net operating loss carryforwards
|
|
$
|
109,000
|
|
|
$
|
91,000
|
|
Less valuation allowance
|
|
|
(109,000
|
)
|
|
|
(91,000
|
)
|
|
|
|
|
|
|
|
|
|
Net Deferred Tax Assets
|
|
$
|
-
|
|
|
$
|
-
|
|
During the six months ended June 30, 2016 and the year ended
December 31, 2015, respectively, the valuation allowance against the deferred tax assets increased by approximately $18,000 and
$(17,400).
Note J - Common Stock Transactions
On March 8, 2016, the Company sold 12,011,000 shares of its
common stock to David Selakovic for approximately $303,100 in cash. The Company received $100,000 in the fourth quarter of 2015
and the remaining balance during the six months ended June 30, 2016.
In May 2016, the Company completed a private offering of 1,000,000
shares of common stock for $500,000 in cash.
Note K- Subsequent Events
Management has evaluated all other activity of the Company through
the release date of these financial statements and have concluded that no other subsequent events have occurred that would require
recognition in the accompanying financial statements or disclosure in the notes to financial statements.